Skip to content
AnalystLens

Labcorp Holdings 8-K Report, Regulation FD Disclosure (Oct 10, 2024)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed October 10, 2024
Period End
October 9, 2024
Security
LH
In the record · 2016–202610-K1310-Q338-K382

LH filed 13 annual reports (10-K), 33 quarterly reports (10-Q) and 382 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Sep ’17Sep ’17
  2. Auditor change8-K · Nov ’20Nov ’20
  3. Leadership change8-K · Oct ’22Oct ’22
  4. Leadership change8-K · Aug ’26Aug ’26

01—Abstract

Summary

Summary of the 8-K filed October 10, 2024. Cited figures are marked; the original filing is the authoritative source.

On October 10, 2024, Labcorp Holdings Inc. (LH) filed a Current Report on Form 8-K under Item 7.01 (Regulation FD Disclosure) to announce that its Board of Directors has declared a quarterly cash dividend of $0.72a per share of common stock.

The dividend is payable on December 13, 2024, to stockholders of record as of the close of business on November 26, 2024. The announcement is furnished as Exhibit 99.1, a press release dated October 10, 2024, which describes Labcorp as a global leader in laboratory services with more than 67,000 employees serving clients in approximately 100 countries. The release states that the company supported 84%b of new drugs and therapeutic products approved by the FDA in 2023 and performed more than 600 million tests for patients worldwide.

For investors, the filing's substance is limited to the dividend declaration and its key dates. The filing does not discuss financial results, guidance, or other operating developments.

02—Key points

Key Highlights

  1. Board of Directors declared a cash dividend of $0.72 per share of common stock.
  2. Dividend payable December 13, 2024.
  3. Record date for dividend eligibility is the close of business on November 26, 2024.
  4. Disclosure furnished under Item 7.01 (Regulation FD) and incorporated by reference via Exhibit 99.1 press release dated October 10, 2024.
  5. Labcorp reports more than 67,000 employees and clients in approximately 100 countries, per the press release boilerplate.
  6. The company states it supported 84% of new drugs and therapeutic products approved by the FDA in 2023 and performed more than 600 million tests.

03—Questions

Frequently Asked Questions

  1. How much is the dividend and when is it paid?

    Labcorp's Board declared a cash dividend of $0.72 per share of common stock, payable on December 13, 2024.

  2. Who is eligible to receive the dividend?

    Stockholders of record as of the close of business on November 26, 2024, are eligible to receive the dividend.

  3. Does this filing contain financial results or guidance?

    No. The filing covers only the dividend declaration and related dates; it does not include financial results or guidance.

  4. Where is the full announcement?

    The full press release dated October 10, 2024, is furnished as Exhibit 99.1 and incorporated by reference into the filing.

04—Continue

← View all 8-K filings